John Orwin, President & CEO, Director at Relypsa Inc, holds 3.33K shares in AnaptysBio (Ticker: ANAB), holds 28.88K shares in Travere Therapeutics (Ticker: TVTX), holds 77.54K shares in Atreca (Ticker: BCEL).
John Orwin latest transaction was an Uninformative Buy of $52.43K.
What was John Orwin's most profitable transaction?
John Orwin’s most profitable transaction was an Informative Buy of SGEN stock on February 17, 2016. The return on the trade was 107.20%.
What is John Orwin's role in Relypsa Inc?
John Orwin's role in Relypsa Inc is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.